Results 51 to 60 of about 351,337 (287)

Special Libraries, December 1940 [PDF]

, 1940
Volume 31, Issue 10https://scholarworks.sjsu.edu/sla_sl_1940/1009/thumbnail ...
Special Libraries Association
core   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Special Libraries, May-June 1947 [PDF]

, 1946
Volume 38, Issue 5https://scholarworks.sjsu.edu/sla_sl_1947/1004/thumbnail ...
Special Libraries Association
core   +8 more sources

Special Libraries, May-June 1957 [PDF]

, 1956
Volume 48, Issue 5https://scholarworks.sjsu.edu/sla_sl_1957/1004/thumbnail ...
Special Libraries Association
core   +2 more sources

The systematic guideline review: method, rationale, and test on chronic heart failure [PDF]

, 2009
Background: Evidence-based guidelines have the potential to improve healthcare. However, their de-novo-development requires substantial resources-especially for complex conditions, and adaptation may be biased by contextually influenced recommendations ...
A Glasier, A Helou, A McIntosh, A Qaseem, AC Molewijk, Alberta Heritage Foundation for Medical Research (AHFMR), Allen Hutchinson, AR Jonsen, Arzneimittelkommission der deutschen Aerzteschaft, AS Relman, B Fervers, B Fervers, C Beck, C Davenport, C Muth, CA Silagy, Canadian Cardiovascular Society, CD Naylor, Centre for Evidence Based Medicine (CEBM), Christiane Muth, CO Phillips, Council of Europe, D Banta, DA Welle, DC Hadorn, Department of Veterans Affairs & Veterans Health Administration, DN Juurlink, E Van Doorslaer, EJ Emanuel, F Eisinger, FA McAlister, FA McAlister, FE MacLeod, Ferdinand M Gerlach, FM Gerlach, G Feder, GRADE Working Group, I Schubert, ID Graham, ID Graham, Institute for Clinical System Improvement, J Cohen, J Craig, J DeMaeseneer, J Dixon, J Watine, JA Doust, JA Knottnerus, JC Watine, JG Lijmer, Jochen Gensichen, JS Burgers, KF Adams Jr, M Battaglia, M Berg, M Komajda, M Kulig, Martin Beyer, MF Piepoli, National Heart Foundation of Australia and Cardiac Society of Australia & New Zealand, NK Choudhry, Ontario Program for Optimal Therapeutics, P Shekelle, P Shekelle, P Vineis, PG Shekelle, PP Budetti, R Aldrich, R Ashcroft, R Busse, R Faris, R Foy, R Taylor, R Thomson, R Voellinger, R Wabitsch, RE Ashcroft, SA Hunt, SH Woolf, SH Woolf, T Christiaens, T Kaiser, The AGREE Collaboration, The AGREE Collaboration, The Finnish Medical Society Duodecim, The National Collaborating Centre for Chronic Conditions, The National Heart Foundation of New Zealand, TM Shaneyfelt, TS Ravago, U Alehagen, U Siebert, UC Hoppe, University Witten/Herdecke, W Rosenberg, WE Chavey 2nd, WE Chavey 2nd, WJ Remme, WP Oosterhuis, WS Richardson   +98 more
core   +3 more sources

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Special Libraries, April 1940 [PDF]

, 1939
Volume 31, Issue 4https://scholarworks.sjsu.edu/sla_sl_1940/1003/thumbnail ...
Special Libraries Association
core   +4 more sources

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

50 Jahre Arbeitsgemeinschaft für Medizinisches Bibliothekswesen (AGMB): Vorsitzende der AGMB beantworten Fragen zur Rolle von Medizinbibliotheken im Wandel der Zeiten

GMS Medizin – Bibliothek – Information, 2020
The German Medical Library Association (AGMB) was founded in 1970, so it had its 50 anniversary in 2020. Due to the effects of the Covid-19 pandemic, no anniversary celebration could take place.
Bauer, Bruno, Dollfuß, Helmut
doaj   +1 more source

Medizinbibliothekenbeta – Konstant im Wandel

, 2013
The focus of the current issue 3/2013 of GMS Medizin – Bibliothek – Information is the annual conference 2013 of the German Medical Libraries Association in Berlin. The motto of the conference was “Medical librariesbeta – Change is the constant”.
B. Bauer
semanticscholar   +1 more source